A company submitted study data supporting a PMA submission to the FDA.
Steady: 1 in the last 7 days
Updated yesterday
The latest in this situation
How it started
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A company submitted study data supporting a PMA submission to the FDA.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Envoy Medical Inc. is submitting PMA modules to the FDA for its pivotal clinical trial.1 source
- Granules India Limited is submitting ANDA and Paragraph IV certification to the FDA.Sub-event
Study data supported PMA submission to the FDA.1 source
Keep exploring
The entities involved
Related events
- The FDA requested additional clinical data from Unicycive Therapeutics.
- Adam Craig reported positive results that could support FDA approval for a treatment.
- BioTech generated encouraging early data for MASH and POTS, and expects an FDA decision regarding cemdisiran next month.
- FDA data is being utilized by Idan Hecht's team, who are affiliated with Mayo Clinic.
- FDA approved a medical device from Abbott and supported a PARADIGM study based on data from the Cleveland Clinic.
Coverage
Newest first; wire copies grouped- saultstar.com
- finanznachrichten.de
- GlobeNewswireNyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine Nyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine Mont-Saint-Guibert, Belgium
- Unknown outlet